Skip to main content
SpringerLink
Log in

POMME cohort valuable tool to assess prenatal drug exposure

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. POMME = PrescriptiOn Médicaments Mères Enfants. Children born in a region of south-west France over a 1-year period are registered in POMME every 5 years. Each 5-year period forms a different cohort for comparative use (i.e. POMME 2010, POMME 2015).

Reference

  • Benevent J, et al. POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure. Drug Safety : [10 pages], 19 Aug 2018. Available from: URL: http://dx.doi.org/10.1007/s40264-018-0712-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

POMME cohort valuable tool to assess prenatal drug exposure. Reactions Weekly 1718, 10 (2018). https://doi.org/10.1007/s40278-018-51354-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-51354-y

Search

Navigation